Case Report: Effect of Electroconvulsive Therapy on Obsessive-Compulsive Disorder Comorbid With Body Dysmorphic Disorder

Ma, Xiaoyan; Li, Ranli

doi:10.3389/fpsyt.2021.706506

Cited by 5 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent report of a 50-year-old woman diagnosed with comorbid treatment-resistant major depressive disorder and body dysmorphic disorder found that electroconvulsive therapy, which has proven value in the treatment of medication-resistant depression, resolved and sustained remission of both conditions for 2 months [4]. Although these findings are initial and further research is required, they suggest that electroconvulsive therapy may be useful in managing more severe cases [4,12]. Other studies have found a potential effect of psychedelics in the treatment of primary features in BDD, but more data about safety and efficiency is necessary [10].…”

Section: Future Directionsmentioning

confidence: 97%

What do we know about body dysmorphic disorder - Review of current knowledge

Brożyna,

Bydliński,

Kwiatkowska

et al. 2024

J Educ Health Sport

View full text Add to dashboard Cite

Introduction Body dysmorphic disorder, also known as dysmorphophobia, is a severe psychiatric disorder characterized by DSM-V as preoccupation with one or more perceived defects or flaws in physical appearance, that are not observable or appear slight to others. BDD can cause significant distress or impairment in social and occupational areas of life. It is often comorbid with other psychiatric conditions like major depressive disorder. Current ways of treatment include a combination of pharmacotherapy and cognitive-behavioral therapy. Aim of the study To summarize current knowledge of body dysmorphic disorder, its pharmacological and non-pharmacological treatment, outline possible areas for further research, and raise the awareness of the disorder. Material and methods The review was based on the PubMed database and was carried out using keywords to determine the latest publications. Summary Body dysmorphic disorder is a relatively common and severe condition that greatly diminishes patients' quality of life. While helpful diagnostic tools exist, BDD diagnosis remains relatively uncommon, posing challenges for patients to receive adequate treatment and continuing their suffering. Despite identifying several factors contributing to the disorder, much remains unknown. Many patients do not respond to standard treatment options, highlighting the need for further studies into the disorder's neurobiology, causes, and alternate treatment approaches to achieve a deeper comprehension of BDD as the number of new cases increases every year.

show abstract

Section: Future Directionsmentioning

confidence: 97%

What do we know about body dysmorphic disorder - Review of current knowledge

Brożyna,

Bydliński,

Kwiatkowska

et al. 2024

J Educ Health Sport

View full text Add to dashboard Cite

show abstract

“…Compared to the general population, all-cause mortality is twice as high, and comorbid other psychiatric disorders can further increase the risk ( 3 ). Estimates suggest that up to 90% of individuals with OCD have a comorbid psychiatric disorder ( 4 , 5 ).…”

Section: Introductionmentioning

confidence: 99%

Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study

Long

Deng

et al. 2022

Front. Psychiatry

View full text Add to dashboard Cite

BackgroundChronic mental diseases such as obsessive-compulsive disorder (OCD) are associated with a high disability rate. Some patients still do not improve their symptoms even with adequate cognitive-behavioral therapy and drug treatment. In the treatment of OCD, electroconvulsive therapy (ECT) is not considered a neuromodulation modality with sufficient evidence.ObjectiveThis retrospective study aimed to determine the efficacy and associated risk factors of ECT in OCD patients.Materials and methodsThe study included 21 OCD patients who underwent ECT at a high-volume center in China between January 2009 and December 2020. The demographics and clinical characteristics of the patients were assessed using descriptive statistics. Based on Clinical Global Impressions–Improvement scale, patients were categorized into response and non-response groups. Clinical and demographic characteristics of two groups of patients were compared.ResultsAn analysis of 21 patients was conducted. In total, 12 patients (57.1%) responded to ECT, 11 patients (52.4%) reported side effects, and an average of 7 ECT sessions were administered. In terms of demographic, there was no statistically significant difference between the two groups. It is noteworthy that the non-response group reported more depression and schizophrenia related disorders comorbidities than the response group (χ2 = 6.252, P = 0.041).ConclusionThe effectiveness of ECT in treating OCD is limited, especially in patients with refractory symptoms. Comorbidity with other mental disorders may affect the efficacy of ECT.

show abstract

Alprazolam/aripiprazole/fluoxetine

2022

Reactions Weekly

View full text Add to dashboard Cite

Case Report: Effect of Electroconvulsive Therapy on Obsessive-Compulsive Disorder Comorbid With Body Dysmorphic Disorder

Cited by 5 publications

References 19 publications

What do we know about body dysmorphic disorder - Review of current knowledge

What do we know about body dysmorphic disorder - Review of current knowledge

Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study

Alprazolam/aripiprazole/fluoxetine

Contact Info

Product

Resources

About